Advertisement

week in cancer news

  • October 15: The Week in Cancer News

    FDA authorizes electronic cigarette for the first time, and a new survey explores marijuana use in breast cancer patients

    by Eric Fitzsimmons

  • October 8: The Week in Cancer News

    A study shows the cost of drugs that manage cancer-related symptoms adds up, and experts explore research at the AACR conference on cancer disparities.

    by Marci A. Landsmann

  • October 1: The Week in Cancer News

    MRI can be a cost-effective way to screen for breast cancer, and a new study investigates the impact of higher alcohol taxes on cancer incidence

    by Kevin McLaughlin

  • September 24: The Week in Cancer News

    Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and a new study compares HER2-targeted therapies in metastatic breast cancer.

    by Eric Fitzsimmons

  • September 17: The Week in Cancer News

    An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.

    by Kevin McLaughlin

  • September 10: The Week in Cancer News

    9/11 first responders’ cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

    by Marci A. Landsmann

  • September 3: The Week in Cancer News

    Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.

    by Bradley Jones

  • August 27: The Week in Cancer News

    Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

    by Bradley Jones

  • August 20: The Week in Cancer News

    Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

    by Marci A. Landsmann

  • August 13: The Week in Cancer News

    Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

    by Kevin McLaughlin

Advertisement
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR